7Baggers
 rhumbline advisers reduces position in aura biosciences, inc. $aura  Defense World Thu, 25 Sep 2025 07:32:00 GMT
 published on: 2025-09-19 14:48:58  خودرو بانک Fri, 19 Sep 2025 11:20:05 GMT
 Sabine Brookman-May: TAR200 Approved for BCG-Unresponsive NMIBC  Oncodaily Sun, 14 Sep 2025 11:38:39 GMT
 FDA Approval of INLEXZO for BCG-Unresponsive Bladder Cancer  Oncodaily Thu, 11 Sep 2025 07:00:00 GMT
 deutsche bank ag trims stake in aura biosciences, inc. $aura  Defense World Sun, 31 Aug 2025 12:40:15 GMT

Aura Biosciences
(NASDAQ:AURA) 

AURA stock logo

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the fi...

Founded: 2007
CEO / Founder: Eli de los Pinos 
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends